慕康生醫
539815.85+0.05+0.32%收盤・資料日 2026-11-06
每股盈餘左軸 EPS、右軸股價
2026 Q20.14 元—
單季 EPS（元）
202120222023202420252026
盈餘表新到舊
| 季別 | EPS（元） | 季增率 | 年增率 |
|---|---|---|---|
| 2026 Q2 | 0.14 | — | −62.16% |
| 2026 Q1 | −0.22 | −466.67% | — |
| 2026 Q1–Q2 合計 | −0.08 | −147.06% | |
| 2025 Q4 | 0.06 | −50.00% | — |
| 2025 Q3 | 0.12 | −67.57% | +140.00% |
| 2025 Q2 | 0.37 | — | +131.25% |
| 2025 Q1 | −0.20 | — | −766.67% |
| 2025 全年合計 | 0.35 | +66.67% | |
| 2024 Q4 | −0.03 | −160.00% | — |
| 2024 Q3 | 0.05 | −68.75% | — |
| 2024 Q2 | 0.16 | +433.33% | — |
| 2024 Q1 | 0.03 | — | — |
| 2024 全年合計 | 0.21 | — | |
| 2023 Q4 | −0.26 | — | — |
| 2023 Q3 | −0.10 | — | — |
| 2023 Q2 | 0.00 | — | −100.00% |
| 2023 Q1 | −0.29 | — | — |
| 2023 全年合計 | −0.65 | — | |
| 2022 Q4 | −0.14 | — | — |
| 2022 Q3 | 0.00 | −100.00% | — |
| 2022 Q2 | 0.10 | — | −56.52% |
| 2022 Q1 | −0.09 | — | −156.25% |
| 2022 全年合計 | −0.13 | −139.39% | |
| 2021 Q4 | −0.06 | — | −126.09% |
| 2021 Q3 | 0.00 | −100.00% | — |
| 2021 全年合計 | 0.33 | −2.94% |
三率
2026 Q235.80%2.98%18.24%
三率（%）
202120222023202420252026
三率明細單季
| 期間 | 毛利率 | 營益率 | 淨利率 |
|---|---|---|---|
| 2026 Q2 | 35.80% | 2.98% | 18.24% |
| 2026 Q1 | 0.47% | −43.27% | −37.86% |
| 2025 Q4 | 37.93% | 3.61% | 5.24% |
| 2025 Q3 | 35.72% | 10.22% | 8.13% |
| 2025 Q2 | 52.59% | 21.79% | 24.10% |
| 2025 Q1 | −6.73% | −54.54% | −38.02% |
| 2024 Q4 | 30.64% | −0.91% | −2.31% |
| 2024 Q3 | 35.47% | 7.25% | 3.92% |
| 2024 Q2 | 40.68% | 7.99% | 11.91% |
| 2024 Q1 | 34.64% | −8.86% | 3.86% |
| 2023 Q4 | 6.68% | −39.29% | −35.69% |
| 2023 Q3 | 20.59% | −16.41% | −9.98% |
| 2023 Q2 | 25.76% | −8.34% | 0.31% |
| 2023 Q1 | 12.30% | −27.80% | −28.11% |
| 2022 Q4 | 18.69% | −6.68% | −9.21% |
| 2022 Q3 | 23.01% | −7.96% | −0.40% |
| 2022 Q2 | 30.66% | 1.50% | 7.66% |
| 2022 Q1 | 31.25% | −6.52% | −8.17% |
| 2021 Q4 | 28.05% | −9.21% | −4.43% |
| 2021 Q3 | 35.94% | 6.16% | 0.10% |
ROE 拆解每季都是近四季合計
2026 Q2近四季
ROE0.91%−0.93 個百分點
＝淨利率2.49%−1.57 個百分點
×總資產週轉0.32 次−0.05 次
×權益乘數1.13 倍−0.09 倍
ROA 0.77%。和 2025 Q2 比，ROE 減少，變動比率最大的是淨利率。
2026 Q20.91%0.77%
ROE、ROA（近四季合計，%）
202120222023202420252026
2026 Q22.49%
淨利率（近四季，%）
202120222023202420252026
2026 Q20.32 次
總資產週轉（近四季合計，次）
202120222023202420252026
2026 Q21.13 倍
權益乘數（倍）
202120222023202420252026
ROE 明細每季都是近四季合計
| 期間 | ROE | ROA | 淨利率 | 總資產週轉（次） | 權益乘數（倍） |
|---|---|---|---|---|---|
| 2026 Q2 | 0.91% | 0.77% | 2.49% | 0.32 | 1.13 |
| 2026 Q1 | 2.95% | 2.51% | 6.93% | 0.38 | 1.13 |
| 2025 Q4 | 3.26% | 2.83% | 7.55% | 0.37 | 1.17 |
| 2025 Q3 | 2.44% | 2.12% | 5.31% | 0.38 | 1.21 |
| 2025 Q2 | 1.83% | 1.60% | 4.06% | 0.37 | 1.22 |
| 2025 Q1 | −0.14% | −0.23% | −0.41% | 0.34 | 1.00 |
| 2024 Q4 | 1.96% | 1.57% | 4.32% | 0.36 | 1.25 |
| 2024 Q3 | −0.27% | −0.46% | −0.41% | 0.33 | 2.04 |
| 2024 Q2 | −1.72% | −1.72% | −4.48% | 0.31 | 1.24 |
| 2024 Q1 | −3.14% | −2.84% | −8.90% | 0.31 | 1.15 |
| 2023 Q4 | −6.09% | −5.45% | −16.49% | 0.33 | 1.12 |
| 2023 Q3 | −4.83% | −4.31% | −11.16% | 0.39 | 1.12 |
| 2023 Q2 | −3.92% | −3.49% | −8.75% | 0.40 | 1.13 |
| 2023 Q1 | −3.04% | −2.72% | −6.52% | 0.41 | 1.15 |
| 2022 Q4 | −1.22% | −1.10% | −2.67% | 0.41 | 1.11 |
| 2022 Q3 | −0.47% | −0.42% | −1.12% | 0.39 | 1.07 |
| 2022 Q2 | −0.41% | −0.38% | −0.97% | 0.40 | 1.07 |
| 2022 Q1 | 0.61% | 0.55% | 1.21% | 0.49 | 1.02 |
| 2021 Q4 | 2.79% | 2.46% | 4.61% | 0.54 | 1.12 |
| 2021 Q3 | 5.32% | 4.69% | 7.68% | 0.61 | 1.14 |